Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Ophthalmic Surg Lasers Imaging Retina ; 52(3): 116-122, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-34038685

RESUMO

BACKGROUND AND OBJECTIVE: To quantify fractal dimension (FD) by mass-radius method in optical coherence tomography angiography (OCTA) images and characterize microvascular differences in eyes with and without diabetic retinopathy (DR). PATIENTS AND METHODS: A retrospective study was conducted using OCTA images of 3 mm × 3 mm and 6 mm × 6 mm scans for superficial and deep capillary plexuses from 49 control eyes and 58 eyes with DR. RESULTS: Analysis of variance showed a significant difference between the FD of control and diabetic eyes in deep plexus scans, and the 3 mm × 3 mm superficial plexus scan (P < .05). In the 3 mm × 3 mm superficial plexus, the FD of severe nonproliferative DR (NPDR) and proliferative DR (PDR) were significantly lower compared to control. The scans of the deep plexus showed only severe NPDR was significantly reduced in the 6 mm × 6 mm scan, whereas moderate NPDR, severe NPDR, and PDR were significantly lower in the 3 mm × 3 mm scan. CONCLUSION: The study suggests the use of FD as a measure of microvascular dropout in DR. [Ophthalmic Surg Lasers Imaging Retina. 2021;52:116-122.].


Assuntos
Diabetes Mellitus , Retinopatia Diabética , Retinopatia Diabética/diagnóstico , Angiofluoresceinografia , Fractais , Humanos , Rádio (Anatomia) , Vasos Retinianos/diagnóstico por imagem , Estudos Retrospectivos , Tomografia de Coerência Óptica
2.
Retin Cases Brief Rep ; 14(4): 364-367, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-29443807

RESUMO

PURPOSE: To report multimodal imaging in a novel case of angioid streaks in a patient with Turner syndrome with 10-year follow-up. METHODS: Case report of a patient with Turner syndrome and angioid streaks followed at Bellevue Hospital Eye Clinic from 2007 to 2017. Fundus photography, fluorescein angiography, and optical coherence tomography angiography were obtained. RESULTS: Angioid streaks with choroidal neovascularization were noted in this patient with Turner syndrome without other systemic conditions previously correlated with angioid streaks. CONCLUSION: We report a case of angioid streaks with choroidal neovascularization in a patient with Turner syndrome. We demonstrate that angioid streaks, previously associated with pseudoxanthoma elasticum, Ehlers-Danlos syndrome, Paget disease of bone, and hemoglobinopathies, may also be associated with Turner syndrome, and may continue to develop choroidal neovascularization, suggesting the need for careful ophthalmic examination in these patients.


Assuntos
Estrias Angioides/diagnóstico , Estrias Angioides/etiologia , Neovascularização de Coroide/etiologia , Síndrome de Turner/complicações , Inibidores da Angiogênese/uso terapêutico , Estrias Angioides/tratamento farmacológico , Bevacizumab/uso terapêutico , Neovascularização de Coroide/diagnóstico , Neovascularização de Coroide/tratamento farmacológico , Feminino , Angiofluoresceinografia , Seguimentos , Humanos , Injeções Intravítreas , Imagem Multimodal , Tomografia de Coerência Óptica , Fator A de Crescimento do Endotélio Vascular/antagonistas & inibidores , Acuidade Visual , Adulto Jovem
3.
Br J Ophthalmol ; 100(9): 1211-5, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26659344

RESUMO

BACKGROUND/AIMS: To describe the results of pars plana vitrectomy (PPV) for persistent symptomatic vitreomacular traction (VMT) with or without macular hole (MH) after intravitreal ocriplasmin injection. METHODS: Multicentre retrospective study of eyes that received intravitreal ocriplasmin between January 2013 and January 2014 for symptomatic VMT with or without MH, and then went on to PPV (ocriplasmin-treated group) for persistent pathology, compared with a control group of patients with symptomatic VMT with or without MH who were offered ocriplasmin injection but proceeded directly to PPV (PPV-only group). Intraoperative characteristics, visual acuity (VA) outcomes and spectral-domain optical coherence tomography images were reviewed for the two groups. Primary outcome measure was VA after PPV. RESULTS: 51 eyes of 51 patients underwent PPV after receiving ocriplasmin, and 22 eyes of 22 patients proceeded directly to PPV. Although VA was significantly better at all time points in the PPV-only compared with the ocriplasmin-treated group, at 3 and 6 months after PPV both groups had similar amount of visual improvement. Both groups had similar rates of pathology resolution; 50/51 (98%) eyes in the ocriplasmin group and 22/22 (100%) eyes in the PPV-only group had release of VMT and/or MH closure after PPV. The two groups had similar PPV-related complication rates. CONCLUSIONS: Eyes with persistent symptomatic VMT and/or MH have similarly high rates of pathology resolution as well as similar VA gains regardless of whether they received ocriplasmin prior to PPV.


Assuntos
Fibrinolisina/efeitos adversos , Fragmentos de Peptídeos/efeitos adversos , Retina/diagnóstico por imagem , Perfurações Retinianas/cirurgia , Vitrectomia/métodos , Idoso , Feminino , Fibrinolisina/administração & dosagem , Seguimentos , Humanos , Injeções Intravítreas , Masculino , Fragmentos de Peptídeos/administração & dosagem , Perfurações Retinianas/diagnóstico , Perfurações Retinianas/tratamento farmacológico , Estudos Retrospectivos , Fatores de Tempo , Tomografia de Coerência Óptica , Resultado do Tratamento , Acuidade Visual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA